Evidence map›Paper›PMID 38790116›Full record

ArticleJournal of cosmetic dermatology2024

The synergistic effects of Guaiacum officinale and Rhodomyrtus tomentosa extracts in the treatment of acne vulgaris on sensitive skin.

Jianhua Zhang, Shichao Liu, Wenjiao Guo, Na Li

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jianhua ZhangN.O.D topia (GuangZhou) Biotechnology Co., Ltd., Guangzhou, China.
Shichao LiuN.O.D topia (GuangZhou) Biotechnology Co., Ltd., Guangzhou, China.
Wenjiao GuoN.O.D topia (GuangZhou) Biotechnology Co., Ltd., Guangzhou, China.
Na LiN.O.D topia (GuangZhou) Biotechnology Co., Ltd., Guangzhou, China.ORCID https://orcid.org/0000-0002-1631-4149

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcne vulgaris, a common chronic dermatological condition worldwide, is associated with inflammatory response and Cutibacterium acnes. Individuals with acne vulgaris and sensitive skin have limited suitable treatments due to the skin irritation and side effects exhibited by current hydroxy acidic medications.

aimsThis study aimed to evaluate the synergistic effects of Guaiacum officinale (GO) and Rhodomyrtus Tomentosa (RT) extracts for treating acne vulgaris on sensitive skin by inhibiting inflammation.

methodsThe phytochemical constituents and antioxidant activity of GO and RT extracts were determined in vitro. The anti-inflammatory effects were investigated in peptidoglycan (PGN)-induced HaCaT cells. Further, a 28-day clinical trial was conducted involving 30 subjects with both sensitive skin and acne to evaluate the efficacy and subjects' satisfaction.

resultsTotal phenolics and flavonoids were detected in GO and RT extracts, the IC

conclusionThe efficacy of the GO and RT extracts in synergistically suppressing inflammation, improving acne vulgaris, and reducing redness. The study offers an effective and non-irritant treatment for acne vulgaris in individuals with sensitive skin.

Indexed as

Acne VulgarisDrug SynergismPlant ExtractsAdultAnti-Inflammatory AgentsAntioxidantsFemaleFlavonoidsHaCaT CellsHumansInterleukin-1alphaMaleMyrtaceaePhytotherapySkinToll-Like Receptor 2Anti-Inflammatory AgentsAntioxidantsFlavonoidsInterleukin-1alphaPlant ExtractsTLR2 protein, humanToll-Like Receptor 2Toll-Like Receptor 4acne vulgarisanti‐inflammationGuaiacum officinaleRhodomyrtus tomentosasensitive skin

Identifiers

PMID38790116
PMCPMC13648918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.